Research Site — Warsaw

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

1,142

Registered studies

441

Active

200

Recruiting now

552

Completed

145

Stopped or withdrawn

Most-studied conditions

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms · Type 2 Diabetes Mellitus

Recently updated registry entries

NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT04589845 — Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… (Active Not Recruiting)
NCT06065748 — A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.